Advertise with fastmoving.co.za
 
 

Adcock Ingram acquisition of NutriLida gets Competition Commission Approval
Adcock Ingram acquisition of NutriLida gets Competition Commission Approval

Adcock Ingram acquisition of NutriLida gets Competition Commission Approval

FMCG SUPPLIER NEWS

Adcock Ingram - Aug 4th 2011, 15:10

Adcock Ingram has been given unconditional approval by the Competition Commission to acquire Johannesburg-based supplements business NutriLida Healthcare. The acquisition, which comes into effect on 1 August 2011, will further strengthen Adcock Ingram’s position as the leader in the vitamins, minerals and supplements (VMS) market, while increasing its market share in the broader fast moving consumer goods (FMCG) market.  

NutriLida is renowned for its market leading product range, which targets consumers and healthcare professionals. The NutriLida portfolio includes brands such as ProbiFlora, GynaGuard, ViralGuard, ArthroGuard and Natrodale.

Commenting on the acquisition, Dr Jonathan Louw, CEO of Adcock Ingram, said: “NutriLida has strong brands in several niche market segments. This acquisition, now that it is approved, will enable Adcock Ingram to move further into categories adjacent to our current business and to increase our visibility in the growing self-medication segment.”

Adcock Ingram has grown its presence in the supplements category in recent years. In the previous financial year, over-the-counter product growth was partly driven by supplements and energy products in the FMCG channel. The company already has a strong presence in the tonics market with household brands such as Bioplus®, Vita-thion® and Liviton®.

According to Dr Louw, the South African VMS market has shown substantial growth over the last few years, primarily due to access, availability, an emerging middle class and the increase in proactive health management and self-medication by consumers.

Referring to plans by the Medicines Control Council to introduce regulation around complementary medicines, Dr Louw said: “Adcock Ingram welcomes the plans by the Medicines Control Council to start regulating complementary medicines. As a pharmaceutical company we adhere to the industry standards and therefore support the MCC’s taking control of what has been until now an unregulated arena.”
 

Read more about: supplier news | fmcg | adcock ingram

Related News

AVI hit by constrained consumer spending
13/03/2019 - 12:42
Food and beverage company AVI Limited felt the pinch of constrained consumer spending as income from its shoe brands Green Cross and Spitz slid in the half year to December, resulting in revenue in the footwear and apparel category declining by 9.2 percent to R1.14billion.

Shares in Five Roses owner plummet after dismal trading update
28/01/2019 - 08:56
Fast moving consumer goods group AVI warned shareholders that its interim sales were flat and its headline earnings would decline by up to 7%.

What FMCG companies can learn from the online trading industry
18/12/2018 - 08:09
Fast-Moving Consumer Goods (FMCG) are, by their very nature, products that are designed to be sold quickly at a relatively low cost. Unlike luxury items that often need to sit on the shelf for an extended period of time in order to build up some exclusivity, FMCG products need to be sold as quickly as they’re advertised. With speed being the key ingredient in the FMCG industry, any weak links in the chain can harm a manufacturer's bottom-line.

Listeriosis outbreak haunts Tiger Brands
23/11/2018 - 10:06
The Listeriosis outbreak in South Africa came back to haunt Tiger Brands, with the group reporting a 26 percent decline in headline earnings per share (Heps) to 1 587 cents a share during the year to end September, while revenue fell 9 percent to R15.87.

Black Friday spikes turnover for SMEs
22/11/2018 - 10:50
Even though it is tempting to relegate Black Friday as just another marketing gimmick, the reality is that it signifies the start of a month-long consumer spending frenzy that significantly boosts retail revenues.